Clinical Decision Support AI: Designing Alerts People Actually Use
Introduction
Ninety percent is a striking number for any safety system. That is roughly how often physicians override drug-interaction alerts, according to one meta-analysis. When most warnings are dismissed, the system is not really warning anyone.
This is the problem that clinical decision support AI inherits. Adding machine learning to a decision support tool can improve relevance, but it can also produce more, and noisier, alerts if nobody designs for attention. The most important question is rarely "how smart is the model?" It is "what does the clinician see, when, and what can they do about it?" This article explains why alert fatigue happens and how to design decision support that earns trust.
What Clinical Decision Support Is
Clinical decision support (CDS) delivers patient-specific information or recommendations to clinicians at the point of care. Traditional CDS is rule-based: if a prescribed drug interacts with another, show an alert. AI-enabled CDS adds statistical models that estimate risk, suggest diagnoses or flag anomalies. Both types share the same delivery challenge, which is getting the right information to the right person at the right moment without drowning them.
The Scale of the Problem
Evidence on alert overrides is consistent. A meta-analysis of drug-drug interaction alerts found the overall prevalence of alert override by physicians was 90%. A systematic review of 23 studies in computerized order entry reported average override rates ranging from 46.2% to 96.2%. An outpatient study reviewed 157,483 alerts on about 2 million medication orders and found 52.6% were overridden. The numbers vary because systems, settings and alert types differ. That variation is itself informative.
Overrides Are Not Always Mistakes
It would be tempting to treat every override as clinician error. The data does not support that. In the systematic review above, the share of overrides judged appropriate ranged from 29.4% to 100%, and varied by alert type, from drug-allergy overrides (63.4%-100% appropriate) to drug-drug interaction overrides (0%-95%). In the outpatient study, an average of 53% of overrides were classified as appropriate, ranging from 12% for renal recommendations to 92% for patient allergies.
So some alerts are being dismissed for good reasons because they were not relevant, and some are being dismissed when they should not be. A single override rate cannot tell you which. A separate review of alert fatigue measurement notes that it is unclear how to intervene without a validated measure of alert fatigue, and that override rates may be only a proxy. Treat override data as a starting point for investigation.
Design Principles for Decision Support That Gets Used
Tier Alerts by Severity and Response
Not every message needs to interrupt. Reserve interruptive alerts for high-severity, time-sensitive situations. Move lower-priority information into passive displays that clinicians can consult when relevant.
Fire Only When the Alert Is Actionable
Ask what a clinician can do in response. If the answer is "nothing right now," the information probably belongs elsewhere.
Deliver to the Right Person at the Right Time
An alert sent to a physician that a pharmacist or nurse should handle wastes attention.
Explain the Reason
Reviewers of override data recommend optimizing alert types, providing clear information and explaining the rationale of an alert so essential alerts are not inappropriately overridden. Blog 07 in this series covers explainable AI in more depth.
Make Feedback Cheap
Give clinicians a one-click way to mark an alert as irrelevant, wrong or helpful, with optional structured reasons.
Designing AI-Specific Alerts
Machine learning changes the design problem in a few ways. Thresholds are a choice, not a given: someone decides at what score value an alert fires, and that decision sets alert volume and sensitivity. Consider an "alert budget," deciding how many alerts per clinician per shift are tolerable. Watch for stacking, where multiple models fire on the same patient for related reasons, and consolidate them. Calibrate and validate locally, as Blog 04 explains, since a model that performs well elsewhere may not perform well on your patients.
Measuring Whether It Works
- Override and acceptance rates, broken down by alert type.
- Sampled appropriateness reviews, where clinicians assess whether overrides and acceptances were justified.
- Time to action and outcome measures linked to the clinical purpose of the alert.
- Alert burden per user and per shift.
- Unintended effects, such as delays in other tasks or new workarounds.
Governance and Human Oversight
Decision support influences care, so it should have owners: a multidisciplinary review group with clinicians, pharmacists, nurses, informatics and IT, a documented intended use for each alert, a change-control process, and a route for frontline staff to report concerns. The tool assists clinicians, and accountability for care decisions remains with them.
Implementation Considerations
- Start with a narrow use case and an engaged clinical champion.
- Prototype in silent mode and review what would have fired.
- Co-design with the users who will receive the alerts.
- Integrate into the EHR workflow rather than a separate window.
- Plan maintenance, since clinical guidelines and populations change.
Bottom Line
Better models do not fix alert fatigue by themselves. Well-designed decision support treats clinician attention as a scarce resource, tiers messages by importance, explains its reasoning, measures what happens after an alert fires, and keeps humans in charge. The goal is fewer, better alerts, not more of them.
This article is educational and does not provide medical advice.
Suggested Internal Links
Sources / References
- Felisberto et al., "Override rate of drug-drug interaction alerts in clinical decision support systems: a brief systematic review and meta-analysis," Health Informatics Journal:
- "Appropriateness of Overridden Alerts in Computerized Physician Order Entry: Systematic Review," JMIR Medical Informatics 2020
- "Overrides of medication-related clinical decision support alerts in outpatients," PubMed:
- "Alert fatigue measurement in clinical decision support: a systematic review," PMC:
CTA
Decision support succeeds when the software fits the way clinicians actually work. Techverse Solutions can help teams think through integration, workflow automation and AI components for healthcare software projects. If you're planning a decision support initiative, schedule a conversation with us to map out the technical approach.
Expert in AI solutions and enterprise software development. Helping US companies build and scale technology products.
Get a Free Project Blueprint
Tell us about your idea. We'll respond within 24 hours with a scope, timeline, and cost estimate — no commitment needed.
No spam · NDA available · Free always